ANTX Next Earnings Date Notes

— AN2 Therapeutics (NASDAQ: ANTX) is a clinical-stage biopharmaceutical company focused on developing novel treatments for rare, chronic, & serious infectious diseases with high unmet medical needs. Its lead candidate, epetraborole, is in Phase 3 trials targeting nontuberculous mycobacterial (NTM) lung disease, a difficult-to-treat condition with limited options. For investors listening to ANTX's upcoming earnings call, the most relevant business metrics to track include pipeline progress (especially clinical updates & regulatory milestones for epetraborole), cash runway & operating expenses, as well as partnerships or licensing agreements that enhance long-term value. Unlike companies with commercial revenue, ANTX's long-term prospects hinge on successful clinical results, regulatory submissions, & potential future commercialization plans or collaborations. Keep an eye on patient enrollment updates, top-line data readouts, and any signals regarding the size of the target market and competitive landscape. Ultimately, advancements toward regulatory approval, capital management, & strategic partnerships are the core metrics to monitor to best gauge AN2 Therapeutics’ long-term success. The next projected earnings date for ANTX is 11/11/2026 after close (stay tuned for a confirmed earnings date once announced).

ANTX Next Earnings Date FAQ

On this page we presented the ANTX Next Earnings Date information for AN2 Therapeutics along with recent past earnings dates. For Q2 of 2026, ANTX reported earnings of -0.180/share, with the earnings report taking place on 8/11/2026. For Q1 of 2026, ANTX reported earnings of -0.290/share, with the earnings report taking place on 5/11/2026. For Q4 of 2025, ANTX reported earnings of -0.290/share, with the earnings report taking place on 3/17/2026. For Q3 of 2025, ANTX reported earnings of -0.310/share, with the earnings report taking place on 11/12/2025. For Q2 of 2025, ANTX reported earnings of -0.210/share, with the earnings report taking place on 8/12/2025. Based on these past earnings dates, the projected next earnings date for ANTX is 11/11/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as AN2 Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to AN2 Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research AN2 Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next ANTX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up ANTX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the ANTX next earnings date.